NCT06910059

Brief Summary

The goal of this observational study is to assess inter-/intra- ventricular synchrony and ECG characteristics in relation to Micra tip location. The secondary objective is (1) to identify an optimal Micra pacing location to improve LV function, (2) to investigate the correlation between Micra tip location and tricuspid regurgitation, and (3) to investigate whether Micra location would impact AV synchrony. Patients with pacing indications who plan to receive Micra AV implantation will be recruited.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
4mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jun 2025Aug 2026

First Submitted

Initial submission to the registry

March 14, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 4, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

June 17, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

1.2 years

First QC Date

March 14, 2025

Last Update Submit

April 29, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of ECG characteristics in relation to Micra tip location

    Patients' ECG will be measured to see whether there is difference in ECG characteristics between Micra tip locations.

    Within 6 months after the surgery.

Secondary Outcomes (2)

  • Cardiac functional changes

    Within 6 months after the surgery.

  • To investigate whether Micra location would impact AV synchrony

    Within 6 months after the surgery.

Interventions

It is a observational study and patients with pacing indications who plan to receive Micra AV implantation will be recruited. No intervention procedure will be performed.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study will enroll up to 40 subjects in site. Patients with pacing indications who plan to receive Micra AV implantation will be selected.

You may qualify if:

  • Patients aged above 18 years old
  • Patients who are willing to provide Informed Consent
  • Patients with Class I or II indications who plan to receive a leadless pacemaker, including SSS, AVB, AF with bradycardia, etc.
  • Patients who plan to conduct a cardiac CT scan after implantation

You may not qualify if:

  • Patients with lead retention
  • Patients had heart valve replacement
  • Patients diagnosed with ischemic heart diseases
  • Patients who are allergic to or refuse to use contrast in CT scans
  • Patients who are pregnant or have a plan for pregnancy during the study
  • Patients with medical conditions that would limit study participation
  • Patients already enrolled in another clinical trial which would impact participation of this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Teaching Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, China

Location

Related Publications (3)

  • Reynolds D, Duray GZ, Omar R, Soejima K, Neuzil P, Zhang S, Narasimhan C, Steinwender C, Brugada J, Lloyd M, Roberts PR, Sagi V, Hummel J, Bongiorni MG, Knops RE, Ellis CR, Gornick CC, Bernabei MA, Laager V, Stromberg K, Williams ER, Hudnall JH, Ritter P; Micra Transcatheter Pacing Study Group. A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med. 2016 Feb 11;374(6):533-41. doi: 10.1056/NEJMoa1511643. Epub 2015 Nov 9.

  • Udo EO, Zuithoff NP, van Hemel NM, de Cock CC, Hendriks T, Doevendans PA, Moons KG. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012 May;9(5):728-35. doi: 10.1016/j.hrthm.2011.12.014. Epub 2011 Dec 17.

  • Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014 May;35(18):1186-94. doi: 10.1093/eurheartj/eht511. Epub 2013 Dec 17.

MeSH Terms

Conditions

Atrioventricular BlockAtrial Fibrillation

Interventions

Watchful Waiting

Condition Hierarchy (Ancestors)

Heart BlockArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services Administration

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2025

First Posted

April 4, 2025

Study Start

June 17, 2025

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations